PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7986393-6	1994	The number and morphologic change of SH-SY5Y cells were evaluated in the serum free medium added GM1 ganglioside with insulin or PDGF.	G(M1) Ganglioside	97-112	insulin	Homo sapiens	118-125	
12974752-5	2003	Mechanistically we found that uptake or transport of insulin-CTB conjugates in the gut occurs at least partially via binding to GM-1, which would explain the enhanced clinical efficacy.	G(M1) Ganglioside	128-132	insulin	Homo sapiens	53-60	
9788349-4	1998	Transgenic potato tubers produced 0.1% of total soluble protein as the pentameric CTB-insulin fusion, which retained GM1-ganglioside binding affinity and native antigenicity of both CTB and insulin.	G(M1) Ganglioside	117-132	insulin	Homo sapiens	86-93	
31013778-6	2019	First, it was shown that increased GM1 levels associated with aging/senescence contribute to insulin resistance in human aortic endothelial cells (HAECs).	G(M1) Ganglioside	35-38	insulin	Homo sapiens	93-100	
20504586-6	1990	In the same animal model peripheral, but not central, administration of GM1 reduced the hypoglycemia-induced increase of cerebral blood flow and increased the survival time observed after the insulin injection.	G(M1) Ganglioside	72-75	insulin	Homo sapiens	192-199	
26338710-0	2015	Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells.	G(M1) Ganglioside	12-15	insulin	Homo sapiens	44-51	
29464018-0	2018	Ganglioside GM1 contributes to extracellular/intracellular regulation of insulin resistance, impairment of insulin signaling and down-stream eNOS activation, in human aortic endothelial cells after short- or long-term exposure to TNFalpha.	G(M1) Ganglioside	12-15	insulin	Homo sapiens	73-80	
29464018-8	2018	Our data suggest that GM1 is a key player in the induction of vascular insulin resistance after short- or long-term exposure to TNFalpha and is a good extracellular target for prevention and cure of vascular diseases.	G(M1) Ganglioside	22-25	insulin	Homo sapiens	71-78	
26338710-10	2015	GM1 may be an attractive target for the detection, prevention, and therapy of insulin resistance and related vascular diseases, particularly in older people.	G(M1) Ganglioside	0-3	insulin	Homo sapiens	78-85